Evolut™ EXPAND TAVR II Pivotal Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.
Epistemonikos ID: 6206d3edca011d36876ea67ff6edd0b37595b764
First added on: May 09, 2024